Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis

Hennig, Stephanie and Stanning, Joseph and Staatz, Christine and Thomson, Alison (2013) Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis. Clinical Pharmacokinetics, 52 (4). pp. 289-301. ISSN 0312-5963

Full text not available in this repository.Request a copy from the Strathclyde author

Abstract

While several studies have examined the pharmacokinetics of tobramycin in patients with cystic fibrosis (CF), there is no consensus on whether they differ in patients with and without CF. The objectives of this study were to identify covariates which explain pharmacokinetic variability and to examine whether having the disease CF in itself alters these relationships and drug dose requirements.

Creators(s): Hennig, Stephanie, Stanning, Joseph, Staatz, Christine and Thomson, Alison ORCID logoORCID: https://orcid.org/0000-0002-2354-6116;
Item type:Article
ID code:42317
Keywords:tobramycin, cystic fibrosis, pharmacokinetics, pharmacometrics, patients, Pharmacy and materia medica, Pharmacology, Pharmacology (medical)
Subjects:Medicine > Pharmacy and materia medica
Department:Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Depositing user: Pure Administrator
Date deposited:07 Dec 2012 15:55
Last modified:12 Feb 2021 04:25
URI:https://strathprints.strath.ac.uk/id/eprint/42317
Export data:
CORE (COnnecting REpositories)